COVID-19 Infection Manifesting with Lumbar Spondylodiscitis Complicating With Psoas Abscess without Pneumonia

dc.authoridKibici, Kenan/0000-0002-5912-9648
dc.contributor.authorErok, Berrin
dc.contributor.authorKibici, Kenan
dc.date.accessioned2025-02-06T17:58:23Z
dc.date.available2025-02-06T17:58:23Z
dc.date.issued2021
dc.departmentAltınbaş Üniversitesien_US
dc.description.abstractExtrapulmonary manifestations of COVID-19 (Coronavirus disease 2019) are increasingly recognized. Secondary spinal infections are dangerous complications reported in a few cases in the literature. However, to our knowledge, there is no reported case of a severe spondylodiscitis (SD) complicated with a large psoas abscess in a COVID-19 patient. We would like to report a 43-year-old male patient living in central Anatolia and dealing with farming who presented to the hospital with a complaint of severe back pain. The patient who was given oral treatment with analgesic, anti-inflammatory, and myorelaxant agents was readmitted with increased complaints. His nasopharyngeal swab was positive for COVID-19 without pneumonia on chest computed tomography (CT). He spent the quarantine and treatment period at home but was admitted to our outpatient clinic with a wheelchair with increased complaints and right leg pain preventing daily activities. The control nasopharyngeal swab was negative for COVID-19 but further increase in C-reactive protein (CRP) (152,8 mg/L) and creatine kinase (CK) level (549 IU/L) were revealed. Lumbar magnetic resonance imaging (MRI) showed SD in the L3-L4 level along with right-sided prevertebral inflammatory soft tissue and a large right psoas muscle abscess. Pyogenic lumbar SD complicated with the right psoas abscess in the setting of COVID-19 was considered and antibacterial treatment was started following hospitalization. On the same day, percutaneous aspiration from the psoas abscess under CT guidance was performed and revealed no growth in the culture. After 3 weeks, follow-up MRI showed worsening of all the bone, soft tissue and disc findings. Myalgia is a common manifestation in viral infections, which was also demonstrated in COVID-19 patients, with possible increase in muscle enzymes. Secondary spinal infections and its soft-tissue complications should be considered in the management of COVID-19 patients with neuromuscular symptoms, and detailed neurological and neurosurgical evaluation should be performed in order to avoid progression and permanent damage.en_US
dc.identifier.doi10.1055/s-0041-1741405
dc.identifier.issn2277-954X
dc.identifier.issn2277-9167
dc.identifier.scopus2-s2.0-85132437713
dc.identifier.scopusqualityQ4en_US
dc.identifier.urihttps://doi.org/10.1055/s-0041-1741405
dc.identifier.urihttps://hdl.handle.net/20.500.12939/5211
dc.identifier.wosWOS:000733966000001
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoenen_US
dc.publisherGeorg Thieme Verlag Kgen_US
dc.relation.ispartofIndian Journal of Neurosurgeryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmzKA_WOS_20250206
dc.subjectCovid-19en_US
dc.subjectSars-CoV-2en_US
dc.subjectspondylodiscitisen_US
dc.subjectpsoas abscessen_US
dc.subjectendotheliitisen_US
dc.titleCOVID-19 Infection Manifesting with Lumbar Spondylodiscitis Complicating With Psoas Abscess without Pneumoniaen_US
dc.typeArticleen_US

Dosyalar